N-Glycolylneuraminic acid (Neu5Gc) is the second most populous sialic acid (Sia). The only known biosynthetic pathway of Neu5Gc is the hydroxylation of cytidine-5′-monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac), catalyzed by CMP-Neu5Ac hydroxylase (CMAH). Neu5Gc is abundantly found in mammals except for human, in which CMAH is inactivated due to mutation in the CMAH gene. Evidence has accumulated to show occurrence of Neu5Gc-containing glycoconjugates in sera of cancer patients, human cancerous tissues and cultured human cell lines. Recently, occurrence of natural antibodies against Neu5Gc was shown in healthy humans and is a serious problem for clinical xenotransplantation and stem cell therapies. Studying human occurrence of Neu5Gc is of importance and interest in a broad area of medical sciences. In this study, using a fluorometric high performance liquid chromatography method, we performed quantitative analyses of Sias both inside and in the external environment of the cell and found that (i) incorporation of Neu5Gc was most prominent in soluble glycoproteins found both in the extracellular space and inside the cell as the major Sia compounds. (ii) Of the total Neu5Gc in the Sia compounds that the cells synthesized, 90% was found in the secreted sialoglycoproteins, whereas for Neu5Ac, 70% was found in the secreted sialoglycoproteins. (iii) The Neu5Gc ratio was higher in the secreted sialoglycoproteins (as high as 40% of total Sias) than in intracellular sialoglycoproteins. (iv) The majority of the secreted sialoglycoproteins was anchored on the culture dishes and solubilized by brief trypsin treatment. Based on these findings, a new idea on the mechanism of accumulation of Neu5Gc in cancer cells was proposed.
Introduction
Sialic acid (Sia) is a family of nine-carbon carboxylated sugars having the nonulosonate skeletal structure. This structure is uniquely different from that of other sugar units of animal glycans and important in exerting multiple functions in biological systems. In animal cells, Sias are found most frequently as the terminal sugars of cell surface glycolipids and glycoproteins. Because of its low acid-base dissociation constant, Sia contributes to give negative charge on cell surface under a wide range of physiological pH. In humans, the most abundant Sia is Nacetylneuraminic acid (Neu5Ac). A variety of O-acetyl derivatives of Neu5Ac is also known to occur in species-dependent, tissue-specific and physiological condition-dependent manners. Two other basic structures of Sias are known in animal kingdom. One is N-glycolylneuraminic acid (Neu5Gc) and the other is deaminoneuraminic acid (KDN). In mammals, the biosynthesis of Neu5Gc occurs by hydroxylation of Neu5Ac at the nucleotide sugar level. This is the only known pathway of Neu5Gc biosynthesis, and cytidine-5′-monophosphateNeu5Ac hydroxylase (CMAH) is widely distributed among mammalian species except for human. Thus, Neu5Gc is abundantly found in many kinds of familiar animals, although the significance of its tissue-specific and/or developmental stagedependent modes of occurrence observed has not been fully clarified. In humans, this enzyme is inactivated due to exon depletion/frameshift mutation in the human CMAH gene (Irie et al. 1998) . Despite this fact, evidence has accumulated to show occurrence of Neu5Gc-containing glycoconjugates in sera of cancer patients, human cancerous tissues and cultured human cell lines (reviewed in Malykh et al. 2001) . Various kinds of antibodies specifically recognize conjugated Neu5Gc have been developed. In many reports, especially those appeared earlier, detection of Neu5Gc was only dependent on the reactivity to these antibodies, but in recent works mass spectrometry was also used. Recently, occurrence of Neu5Gc was shown in normal human cells in culture and a minute amount in healthy human tissues, and it was concluded that Neu5Gc was incorporated from external sources, culture media and foods (Tangvoranuntakul et al. 2003) . More recently, many healthy humans were reported to have natural antibodies against Neu5Gc (Zhu and Hurst 2002; Nguyen et al. 2005; Padler-Karavani et al. 2008) . It was also reported that incorporation of Neu5Gc in stem cells was unavoidable as far as animal products were used in culture media (Martin et al. 2005; Heiskanen et al. 2007 ). In contrast to Neu5Gc, biosynthesis of KDN occurs in-dependent of Neu5Ac from a simple sugar, mannose (Angata et al. 1999; Go et al. 2006) . Mammalian occurrence of KDN is far less abundant than Neu5Ac and Neu5Gc (Inoue et al. 1996) . The expression level of KDN is as low as <0.01 mol% of Neu5Ac and is only detectable by careful analysis using highly sensitive methods (reviewed in Inoue and Kitajima 2006) . Enzymes involved in the biosynthesis of Neu5Ac monosaccharide were shown to work efficiently in the formation of KDN in mammals including human, thus theoretically, KDN monosaccharide can occur in any Neu5Ac-producing mammalian cells if mannose is available. However, because of extremely low efficiency of CMP-Neu5Ac synthase-catalyzed formation of CMP-KDN (Nakata et al. 2001) , glycan-bound KDN is hardly detected in normal mammalian tissues (Inoue et al. 1998; Go et al. 2006) , although a minute amount of glycoprotein-bound KDN was detected in PA-1 when the free KDN level in the cell was aberrantly elevated by culturing the cells in a mannosesupplemented medium . Thus, detection of KDN in human cells and/or body fluid could be a sign of some disorder in mannose metabolism.
In the course of our studies on unusual expression of minor Sias in humans, we noted that the proportion of Neu5Gc was as high as ∼20% of total Sias in a human cell line JHOC-5 (clear cell adenocarcinoma of ovary), while in several other cells examined, this was <6%. Studies established that Neu5Gc present in cultured human cell lines originated from fetal calf serum (FCS) added to the culture medium. However, in many of previous studies, only a minute amount of Neu5Gc was detected using specific antibodies. In some studies, mass spectrometry was also used for detection and quantification of Neu5Gc-containing gangliosides, but in none of these studies attention was paid on quantitative aspects of total incorporation levels of Neu5Gc in human cell. In most of these previous studies, gangliosides were the major molecules of researchers' interest (reviewed in Malykh et al. 2001; Yin et al. 2006) , and little attention was paid in glycoproteins into which Neu5Gc was incorporated. In this study, using a highly sensitive high performance liquid chromatography (HPLC) basis method, we made extensive analyses of Sias present in both inside and the external environment of cells and quantified the extent of Neu5Gc incorporation with particular emphasis on cell line JHOC-5 cultured in an FCS-supplemented medium. Important findings revealed by this study are (i) incorporation of Neu5Gc was most prominent in soluble glycoproteins found both in the extracellular space and inside the cell as the major Sia compounds. (ii) Of the total Neu5Gc in the Sia compounds that the cells synthesized, 90% was found in the secreted sialoglycoproteins, whereas for Neu5Ac, 70% was found in the secreted sialoglycoproteins. (iii) The Neu5Gc/Neu5Ac ratios were higher in the secreted sialoglycoproteins than in intracellular sialoglycoproteins. (iv) The majority of the secreted sialoglycoproteins was anchored on the culture dishes and solubilized by brief trypsin treatment. (v) Several lines of circumstantial evidence suggest that these sialoglycoproteins may be mucin-type glycoproteins, and the secreted ones may represent fully sialylated "mature" mucin molecules previously described. High relative proportions of Neu5Gc as high as 40% of total Sias were often observed in these extracellular mucin-type glycoproteins. Similar extensive sialylation and Neu5Gc incorporation were observed in all of the cell lines, including both human and mouse, examined. Based on these results, a new idea on the mechanism of accumulation of Neu5Gc in epithelial cancer cells was proposed. Additionally, results obtained by this study implicated that scavenging Sias from extracellular sources was much more extensive than generally believed during active synthesis of some types of sialoglycoproteins.
Results
Preliminary observations showing unique features of Sia expression in JHOC cells and occurrence of a large amount of extracellular Neu5Gc-rich compounds in the trypsin supernatants of human and mouse cells cultured in FCS-supplemented media When we analyzed expression levels of Sias in several cell lines cultured in media supplemented with 10% FCS, we noted unusually high level of Neu5Gc in JHOC-5. The proportion of Neu5Gc was as high as ∼20% of total intracellular Sias in JHOC-5, while in other human cell lines, HSKTC (Krukenberg tumor, metastasized from stomach to ovary), HeLa (human cervical carcinoma) and PA-1 (ovarian teratocarcinoma of human), this was <6% (Figure 1 ). In mouse cell lines B16 (melanoma) and RAW264 (macrophage-like cell), despite of having active CMAH gene, the proportion of Neu5Gc was as low as 1-2% of total intracellular Sia (Figure 1) . To show the range from sample to sample deviation, results obtained from four independent analyses for JHOC-5 cells, harvested and analyzed at different occasions are given in Figure 1 .
To examine the mechanism of accumulation of such high levels of Neu5Gc in some human cell line, we carefully analyzed Sias present not only inside the cell but also in the Enrichment of Neu5Gc in human extracellular glycoproteins external environment of the cell. We first determined the amounts Neu5Gc and Neu5Ac in 10 mL of the culture medium to be 135 nmol and 2740 nmol, respectively, and the Neu5Gc vs. Neu5Ac ratio was 5/95. These values were not changed after culturing the cells. Because of the abundant amounts of Sias in the medium, the change after culturing the cell, if any, would be within the analytical error. Next, to examine possible release of cell surface sialoglycoconjugates during the process of harvesting cells, we analyzed Sias in the supernatant solution separated from the cell suspension obtained by mild trypsin treatment when the cells were detached from culture dishes (trypsin supernatant). Surprisingly, the trypsin supernatant of JHOC-5 contained more than 10 times as large amounts of Sias as those present in the cell extract, and the Neu5Gc vs. Neu5Ac ratio in the trypsin supernatant was 42/58, whereas the ratio in the cell extract was 21/79: the proportion of Neu5Gc was much higher in the trypsin supernatant than in the cell extract (Table I ). Since cells attached to culture dishes were thoroughly washed with phosphate-buffered saline (PBS) before trypsin treatment, Sias in the trypsin supernatant were considered to be originated from the cells, and thus Sias in the cell extract (intracellular Sias) plus Sias in the trypsin supernatant (represented extracellular Sias) should be the total Sias that the cell produced. To see if these results were unique to JHOC-5, we made similar analysis for several human and mouse cell lines. As shown in Table I , the amounts of extracellular Sias were larger than the intracellular Sias for most cell lines with only exception of B16 in which the amount of Sias in the trypsin supernatant was almost equal to the amount of intracellular Sias. And the extracellular Neu5Gc vs. Neu5Ac ratios were ∼20/80, whereas intracellular Neu5Gc vs. Neu5Ac ratios were <4/96 for all cell lines other than JHOC-5. It is noted that in all of the cell lines examined, >90% of Neu5Gc was associated with extracellular compounds. Especially in the human cells, intracellular Neu5Gc was as low as 4% of total Neu5Gc, whereas in the mouse cells, this value was somewhat higher, 8-11%. It is noted that comparing between two different human cell lines, JHOC-5 and PA-1, the amounts of both intracellular and extracellular Neu5Gc were similar, whereas a large difference was seen in the amounts of Neu5Ac. The amounts of intracellular and extracellular Neu5Ac in JHOC were 1/9 and 1/3 of those in PA-1 cells. The Neu5Ac level of human cells may be determined by the sum of those synthesized de novo and taken up from the medium, whereas the level of Neu5Gc is determined only by that taken up from the medium. Thus, the low synthetic activity of Neu5Ac in JHOC-5 may result in a low level of Neu5Ac and raise the Neu5Gc vs. Neu5Ac ratio. These findings showed that scavenging Sias from the extracellular source is much more extensive than generally believed at least in some cultured cell lines. As will be shown later, sialoglycoconjugates present in the trypsin supernatant are most likely mucin-type glycoproteins. It has been shown that tumor cells are covered with mucins, which contain a large number of sialylated O-glycans (reviewed in Gendler 2001) . In the synthesis of mucins, rapid supply of abundant Sias may be required. In such situations, cultured cells may efficiently take up Sias from the media and reuse them in sialylation of mucin-type glycoproteins.
Localization of Neu5Gc-rich glycoconjugates in the trypsin supernatant before trypsin treatment of the cell First, we thought that Sias in the trypsin supernatant had originally been associated with cell surface and were solubilized during trypsin treatment, or a part of intracellular soluble Sias leaked out during harvesting of the cells and recovered in the trypsin supernatant. To examine this view, JHOC-5 cells were For each cell line, cells were cultured in two dishes and detached from the dishes by brief trypsin treatment. Sialic acids determined for the cell homogenate and the trypsin supernatant (see "Materials and methods") represent the intracellular and extracellular levels, respectively. Results were based on mean values obtained from two independent analyses for each cell line. Table II . Quantification of Sias recovered in the trypsin supernatant, the scraping supernatant and anchored on the dish of JHOC-5 culture 1900 (35) 3600 (65) 200 (6) 3300 (94) 760 (35) 1400 (65) JHOC cells were cultured in 9-cm dishes to full confluence in 10 mL of the medium containing 10% FCS. After culture medium was removed, cells on the dish were washed three times with 5 mL each of cold PBS. Cells were detached from the dish either by digestion with 1 mL of trypsin/EDTA solution for 3 min at room temperature (dish 1) or scraping with a plastic cell scraper (dish 2), and collected in Eppendorf tubes by low-speed centrifugation. Supernatant solutions were clarified by centrifugation for 5 min at 15,000 rpm before Sia analysis. Dish 2 from which the cells were removed was treated with 1 mL of the trypsin/EDTA solution and the solution was clarified by centrifugation. A 5 μl-portion of each solution was subjected to sialic acid analysis by the DMB/HPLC method after hydrolysis in 0.1 M TFA for 1 h at 80°C.
cultured in a set of two dishes. Cells in dish 1 were detached from the dish by brief trypsin treatment, whereas cells in dish 2 were detached by scraping with a plastic cell scraper without trypsin treatment. In either case, the supernatant solution separated from the cell suspension was subjected to Sia analysis.
As the results depicted in Table II show, the amount of Neu5Gc was significantly lower in the scraping supernatant (dish 2) than in the trypsin supernatant (dish 1). Next, we compared Sia levels of cells harvested from dish 1 and those from dish 2. No significant difference was found in both the amount of Sias and the Neu5Gc vs. Neu5Ac ratios in any subcellular fractions of the cells between dish 1 and dish 2 (vide infra). These results were confusing, since no answer was obtained as to where the Sias in the trypsin supernatant came from. Meanwhile we noted that there remained some substance on the empty dish 2 from which cells had been detached by scraping, whereas the empty dish 1 from which the cells had been detached by trypsin treatment had clear appearance. The substance on the empty dish 2 could be solubilized by brief trypsin treatment, and we found that there was a large amount of Sias in the solution obtained (the third column of Table II) . Furthermore, the Neu5Gc vs. Neu5Ac ratio of this material was 35:65, the value being identical with the ratio in the trypsin supernatant obtained from dish 1. The Neu5Gc vs. Neu5Ac ratio in the scraping supernatant was 6:94. In this study, it was not determined if the Neu5Ac-rich glycoproteins in the scraping supernatant were of the type similar to the Neu5Gc-rich glycoproteins. Nevertheless, the results indicate that Neu5Gc-rich glycoproteins similar to those present in the trypsin supernatant were present on the surface of culture dishes during culture. The observed phenomenon may be explained by following sequences. The Neu5Gc-rich glycoproteins secreted by the cells may have been fixed on the dish by forming insoluble complexes with extracellular matrix (ECM) substances. Trypsin treatment may be effective in loosening the links between Neu5Gc-rich glycoproteins and ECM, and resulted in solubilization of the glycoproteins. The results may lead to an important conclusion that the Neu5Gc-rich glycoproteins solubilized by trypsin treatment were not covalently bound to any cell component. They were fixed on the dishes and did not detach from the dishes by scraping. Major portion of them remained firmly fixed on the dish without diffusing into the culture medium during cell culture. Because these extracellular Neu5Gc-rich glycoproteins were fixed on the culture dishes, the concentration of Neu5Gc adjacent to the cells was kept higher than the medium level during cell growth. And because the Neu5Gc-rich glycoproteins were not covalently bound to the cell component, they were ready to be internalized. Comparison of the amounts and relative proportions of extracellular and intracellular Sias of JHOC-5 cells harvested by trypsin treatment or scraping were summarized in Table III . The results showed that difference in the amount of intracellular Neu5Gc and Neu5Ac was within from sample to sample deviation if cells Cells collected from each dish (see Table II ) were suspended in 1mL of an icecold medium containing 0.25 M sucrose in 3 mM Tris-HCl (pH 7.5) and crushed by hands with a Dounce homogenizer until only a small number of the cells was visible under microscope. A small portion of the homogenate was analyzed for total intracellular Sias by the DMB/HPLC method after hydrolysis in 0.1 M TFA for 1 h at 80°C. 
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were harvested by trypsin treatment or scraping, and the proportion of extracellular Neu5Gc was 80-90% of the total Neu5Gc cell produced, whereas extracellular Neu5Ac was ∼70% of the total Neu5Ac, confirming the results shown in Table I .
Nature of the Neu5Gc-rich glycoconjugates in the trypsin supernatants Overexpression of mucins is a universal feature of most cancers (Bhavanandan 1991; Carraway and Hull 1991) . Some parts of mucin molecules are associated with cell surface forming a layer often called "glycocalyx", and the other parts are excreted into the medium or circulation and become cancerspecific antigens. Since the Neu5Gc-rich glycoconjugates appeared most likely to be mucin-type soluble glycoproteins, molecular size of Sia compounds in the trypsin supernatant was analyzed by gel chromatography on Sephadex G-75. Typical elution profile of Sia compounds in the trypsin supernatant obtained from the culture of JHOC-5 cells is depicted in Figure 2A , and that from PA-1 is depicted in Figure 2B . As shown in Figure 2A , Sia compounds present in the trypsin supernatant of JHOC-5 were eluted in fractions spanning a wide range of molecular size. Elution profiles of Neu5Gc and Neu5Ac appeared to be parallel. More precisely, 31% of total Neu5Gc and 23% of total Neu5Ac were eluted in the high-molecular-weight fraction (tubes 15-24). The Neu5Gc vs. Neu5Ac ratio was 41/59 in this fraction, whereas this ratio was 32/68 in the low-molecular-weight fraction (tubes 25-55). The wide range distribution profile of Sia compounds was also observed in the chromatogram of the trypsin supernatant of PA-1, with the difference in that about half of Sias (51% of total Neu5Gc and 56% of total Neu5Ac) eluted in the high-molecular-weight fraction with the Neu5Gc vs. Neu5Ac ratio of 14/86. Observed molecular size distributions may be the combined sequence of proteolytic fragmentation during trypsin treatment and progressive O-glycosylation and sialylation on O-glycan chains during recycling of the extracellular glycoprotein (Litvinov and Hilkens 1993) . When the scraping supernatant of JHOC-5 cells was subjected to similar chromatography, the majority of Sias eluted in the void fraction ( Figure 2C ). We analyzed the glycan chains liberated by hydrazinolysis of high-molecularweight glycoproteins derived from the trypsin supernatant of JHOC-5 and PA-1. A reverse-phase HPLC analysis of pyridylamino (PA)-oligosaccharide gave one major peak of short PAoligosaccharide, and no peak of the large oligosaccharide. From the retention time comparison, the major peak was identifiable as Siaα2→3Galβ1→3GalNAc-PA (sialyl core 1 or sialyl T) (Kuraya et al. 1993) . The presence of Neu5Gc in the compound under the peak was confirmed (Inoue, to be published). It was reported that in O-glycans attached to MUC1 produced by breast cancer cell lines, truncated core 1 based structures dominated ). Thus, the results supported the idea that the extracellular glycoproteins in the trypsin supernatant were of mucin-type structure having many short O-linked glycan chains to which Neu5Gc was linked.
Differential analysis of Sias distributed in subcellular compartments of JHOC-5 Several different human cell lines were harvested by scraping, disrupted in a hypotonic medium and fractionated by Method 1 (see "Materials and methods"), and expression levels of Sias in soluble and membrane fractions were analyzed. As shown in Table IV , in all cell lines tested, about half an amount of both Neu5Gc and Neu5Ac was found in the ethanol-soluble (ES) fraction. According to previous studies, Sias in the ES fractions 756 obtained from various rat organs were in the free monosaccharide forms or CMP-Sias (Muchmore 1992) . It is unusual if such a large proportion of Sias occurs in free and/or the sugar nucleotide forms in the cells examined in this study. We first tried to determine free Sias in the ES fractions using a method based on the borohydride-sensitive nature of free Sias (Kean and Roseman 1966) . However, the difference between the borohydride-treated sample and the control was within analytical errors both for Neu5Gc and Neu5Ac. So we analyzed size distribution of Sia compounds in the ES fractions by gel chromatography on Sephadex G-75. Typical examples were shown in Figure 3A for JHOC-5, and Figure 3B for PA-1. Surprisingly, large proportions of Sias were eluted in high-molecular-weight fractions. In the ES fraction of JHOC-5, 28% of Neu5Gc and 26% of Neu5Ac were eluted in high-molecular-weight fractions (tubes 11-16). In the ethanol-soluble fraction of PA-1 cells, 32% of Neu5Gc and 37% of Neu5Ac were eluted in high-molecularweight fractions. Thus, the results show that Neu5Gc-containing soluble glycoproteins similar to those present in the trypsin supernatants with respect to the molecular size and sialylation status were also present in the ES fractions of these cells as the major Sia-containing compounds. In these figures, the positions indicated by arrows show where authentic CMP-Neu5Ac and free Sia eluted. However, actual amounts of CMP-Sias and free Sias in the ethanol-soluble fractions may be smaller than those expected from the peaks indicated by arrows since they may be overlapped with low-molecular-weight Neu5Gc-containing soluble glycoproteins. Using different approach, CMP-Sias and free Sias were shown to be minor components compared with sialoglycoconjugates in the cell extracts (vide infra). The presence of Neu5Gc-containing soluble glycoproteins in large proportions of Sia compounds was also revealed by Sephadex G-75 chromatography of the ethanol-soluble fractions of mouse cell line, B16 and RAW264 (data not shown). It appears unusual that such high-molecular-weight sialoglycoproteins exist in soluble form in the cytosol. So we examined if these soluble sialoglycoproteins had originally been associated with some organelles. For this purpose, we disrupted cells in an isotonic medium by Method 2 (see "Materials and methods").
The homogenate thus obtained was subjected to differential centrifugation, and the distribution of Sias in the pellets (P1-P5) and the final supernatant was analyzed. In this study, we did not examine if specific organelle was enriched in each separated fraction as described in the previous paper (Jethmalani et al. 1997) . The typical results were depicted in Figure 4 . Sias were most abundant in P2 (600 g pellet) and in P4 (20,000 g pellet): more than 70% of intracellular Sias were found in these two fractions. Only less than 10% was in the final supernatant, the cytosol fraction. We made independent analyses for four batches of the cells harvested in different occasions. Relative distribution patterns were somewhat variable from batch to batch among P1 (may result from the different proportions of unbroken cells), P4 and P5 (a large amount of soluble sialoglycoconjugates was sometimes found in P5), however, high percentage in P2 and low percentage (<10%) in P3 and the cytosol were constantly obtained. To be noted is, first, percentage distribution of Neu5Gc and Neu5Ac were almost same in all fractions, thus 757 Cells were washed three times with cold PBS on the culture dish and detached from the dish by brief trypsin treatment. The amount of total cell protein was 0.5-0.6 mg/dish for all cell lines. Disruption and fractionation of cells were done in hypotonic media (Method 1) as described under "Materials and methods". 
keeping the relative proportion of Neu5Gc vs. Neu5Ac almost equal (Neu5Gc vs. Neu5Ac ratios, ∼15/85) among fractions. The result indicates that the same free-Sias pool was used in sialylation of glycoconjugates present in all of these fractions. Second, the majority of Sias associated with the pellets were solubilized in 10 mM Tris-HCl (pH 8) buffer (depicted as S in Figure 4) , showing that they were linked to soluble glycoproteins. Only small percentage of Sias was insoluble in aqueous buffer, and became soluble when detergents were added to the buffer (depicted as P in Figure 4) . Next, we performed differential analysis of Sias in all separated fractions to determine free Sias, acid-labile Sias (represented CMP-Sias) and glycan-bound Sias by the method described under "Materials and methods". In Figure 5A -D, typical results for selected fractions, P2, P4, P5 and the cytosol, were depicted. The results show that in the fractions sedimented by centrifugation, the majority of Sias were glycan bound, and only less than 5% were in the form of free and acid-labile Sias. It is again noted that larger portions of both Neu5Gc and Neu5Ac were bound to soluble glycoproteins than insoluble glycoconjugates. In particular, a large portion of Sias was associated with soluble glycoconjugates in the pellet obtained by 100,000 g centrifugation (P5, "microsomal fraction"). These results implicate that the major portion of soluble sialoglycoconjugates was originally associated with organelles in the cell and are in accord with the previous results of immunohistochemical staining with an anti-MUC1 antibody of human ovarian carcinoma (Dong et al. 1997) . Relative distributions of free and acid-labile Sias were higher in the cytosol than P2-P5 as expected. To be noted is in the cytoplasmic pool of free Sias and CMP-Sias, the relative distribution of Neu5Gc was higher than that of Neu5Ac, whereas a large portion of Neu5Ac was glycan bound. The Neu5Gc vs. Neu5Ac ratios of free Sias, CMP-Sias and glycan-bound Sias were 16/84, 21/79 and 3/97, respectively. These results imply the presence of some mechanism of Neu5Gc-enrichment in the pool of free Sias. Further studies using biochemical and molecular biological techniques are needed to clarify these issues. When the cell was disrupted in hypotonic media, all of the soluble sialoglycoproteins originally associated with the organelles were recovered in the "soluble fraction". These properties of the soluble glycoproteins strongly support the idea that they are heavily Oglycosylated and Sia-rich mucin-type glycoproteins.
Discussion
Occurrence of Neu5Gc in human cancer cell lines cultured in the FCS-supplemented media is well documented. However, the quantitative aspect of Neu5Gc incorporation and characterization of glycoconjugates into which Neu5Gc incorporation occurs have been treated only poorly. Our results based on highly sensitive 1,2-diamino-4,5-methylenedioxybenzene (DMB)/HPLC analysis of Sias showed that reexpression of Neu5Gc taken up from external media by cultured cell lines was far more extensive than that evaluated in the past studies.
In most of previous studies on the expression of Neu5Gc in human cancer, anti-Neu5Gc antibodies were used as the major tool for detecting this foreign Sia, although in some studies mass spectrometry was also used to support immunochemical results. Moreover, in most of previous studies, the major target molecules analyzed for Neu5Gc expression were limited to gangliosides. As an exceptional example, there was a study that showed the presence of Neu5Gc-containing O-linked glycans in the mucin isolated from breast tumor (Devine et al. 1991) . They showed that the breast tumor-associated epitope defined by a monoclonal antibody they prepared is an O-linked mucin carbohydrate containing Neu5Gc. The conclusion was deduced by inhibition of the binding to the antibody by free Neu5Gc and porcine stomach mucin (>90% of Sia is Neu5Gc), and the presence of Neu5Gc on human tumor mucin they isolated was confirmed by electrospray mass spectrometry.
In the present study, we showed that the extent of Neu5Gc expression in the soluble glycoconjugates by an ovarian cancer cell line JHOC-5 was of the highest level hitherto reported. We quantified not only intracellular Sias, but also extracellularly secreted Sias. Our results showed that in all of the human and mouse cell lines examined, 89-96% of Neu5Gc and 44-91% of Neu5Ac of the total Sias produced by the cell during culture were found in the extracellular exudates. High proportions of Neu5Gc (16-42% of total Sias) in the extracellular Sias were characteristics commonly observed in all of the cell lines tested in this study. Abundant expression and water-soluble nature of these extracellular Neu5Gc-rich glycoconjugates suggest that they are mucins that are universally expressed on the surface of epithelial cells and secreted in the medium, although substantial evidence to define them as mucins was not given in this study. Under cell culture conditions used in this study, these extracellular Neu5Gc-rich glycoconjugates were found to be anchored on the culture dishes (together with other ECM substances) until they were solubilized by brief trypsin treatment, which may effectively cleave some linkages involved in association of the Neu5Gc-rich glycoconjugates and ECM substances. Overexpression of mucins was reported in many kinds of epithelial tumors, and MUC1 is the first to be cloned, and most extensively studied mucin (Gendler et al. 1987; Gendler 2001) . MUC1 is a type 1 transmembrane protein with an extensively O-glycosylated ectodomain and characterized by high carbohydrate content (50-90% of its molecular mass). Expression of MUC1 has been reported in various histological types of ovarian tumors (including clear cell) and studied in correlation with the invasiveness of the tumors (Dong et al. 1997) . Using a monoclonal antibody, they showed the frequency of simultaneous expression of MUC1 at all subcellular locations, the apical membrane, cytoplasm, vacuoles and extracellular secretions, increased from benign to malignant tumors. More recently, expression of MUC1 gene products in human ovarian carcinomas was shown using an anti-MUC1 antibody that recognizes a carbohydrate epitope of the MUC1 glycoprotein (Feng et al. 2002) . Cell surface staining with the antibody was shown in various histological types of ovarian carcinomas including malignant clear cell tumor. However, no chemical study on glycans expressed in ovarian MUC1 has appeared in the literature.
Glycosylation of MUC1 has been most studied on the molecules expressed in breast cancers (Hanisch and Muller 2000) . Unique mode of MUC1 glycosylation is in its multistep O-glycosylation and sialylation before mature mucin molecules are completed. Furthermore, these multistep processes take place while premature mucin molecules repeat secretion and internalization across plasma membrane (Engel-mann et al. 2005) . Several cycles are believed to be necessary for complete sialylation (Litvinov and Hilkens 1993) . Almost all previous studies reported tumor-associated increase of sialylated glycans and overall increase of sialylation. Although the glycan structures increased in tumor mucins were variable depending the cell type, the level of an α2→3sialyltransferase (ST3Gal-I) activity showed tumorigenesis-dependent increment (Burchell et al. 1999; Dalziel et al. 2001) .
However, in none of these precedent studies on tumor-associated enhancement of sialylation on mucin glycoprotein, attention was paid on the problem of tumor-associated enhanced expression of Neu5Gc in mucin glycoproteins. In the present study, incorporation of Neu5Gc in putative mucins of cancer cell lines was much more extensive than ever believed when the cells were cultured in FCS-containing media. It was reported that free Neu5Gc added in the culture media was taken up at high rate by many kinds of human and chimpanzee cells and incorporated into high-molecular-weight and lowmolecular-weight compounds in the cells (Bardor et al. 2005) . They showed that incorporation of Neu5Gc occurs by utilizing fluid pinocytosis and lysosomal Sia transporter. Neu5Ac competed the use of the same pathway of incorporation with Neu5Gc. It was shown that high levels of incorporation into activated T cells were achieved with 3 mM medium concentration of Neu5Gc, but very little incorporation was observed with 0.3 mM Neu5Gc . Human uptake of Neu5Gc from dietary Neu5Gc was also reported. The authors claimed that minute amount of Neu5Gc was chemically detected in healthy human, and the richest Neu5Gc sources are milk and red meat (Tangvoranuntakul et al. 2003) . However, the question is if eating Neu5Gc-rich foods can raise the serum concentration of Neu5Gc to millimolar levels. We determined the concentrations of free and total Neu5Gc in the medium (10% FCS) to be 0.3-0.7 μM and 8-14 μM, respectively, while the concentrations of free and total Neu5Ac were 0.8-4 μM and 200-300 μM, respectively. The difference in these values before and after culture was within the experimental error, if any. Thus enhanced incorporation of Neu5Gc in the cultured cells observed in our experiment is not likely the consequence of uptake of free Neu5Gc from the medium. According to the proposed pathway, Neu5Gc-containing glycoconjugates in FCS in the culture medium and Neu5Gc-containing glycoconjugates in foods are taken up by human cells by endocytosis, and free Neu5Gc liberated by lysosomal sialidase and exported by lysosomal Sia transporter was incorporated in the glycoconjugates newly synthesized by the cells (Bardor et al. 2005) . Can highlevel Neu5Gc expression in cultured cell lines observed in the present study be explained by this mechanism? How it is possible to increase the proportion of Neu5Gc in the glycoconjugates that the cell synthesizes over the value in the culture medium? Since cultured human cells synthesize de novo only Neu5Ac, the proportion of Neu5Gc in the intracellular pool of free Sias should be decreased from the value in the medium when the medium glycan-bound Sias are taken up by the cells, and free Sias liberated by lysosomal sialidase are exported into the pool. Thus, first of all, there should be some mechanism to account for observed high relative proportions of Neu5Gc in cultured cell lines. As can be seen in Table I , the relative proportions of intracellular Neu5Gc in cell lines other than JHOC-5 were lower than that of the medium. This may be accounted for by high intracellular levels of Neu5Ac resulted from its active de novo synthesis. In JHOC-5, because of reduced de novo Neu5Ac synthesis, both Neu5Gc and the major portion of Neu5Ac in the free Sia pool should have been derived from the exogenous source.
In contrast to intracellular Sias, the large amount and the high relative proportion of extracellular Neu5Gc present in the trypsin supernatant were observed in all of the cell lines examined in this study. If the observed accumulation of Neu5Gc occurs in the MUC1-type glycoproteins, the phenomenon may be explained by the mechanism of maturation of glycan chains by recycling of the mucin glycoprotein. As already described above, complete sialylation of MUC1 was reported to be achieved by repeating internalization and export many times. The process occurs via trans Golgi network where additional sialylation to unsialylated short O-glycan chains and further addition of glycan chains and terminal sugars take place. MUC1 expressed in a human mammary cancer cells molecule was reported to recycle 10 times before maturation. The fully sialylated mature MUC1 molecule is then finally released from the cell into the medium or transported to the lysosomes for degradation (Litvinov and Hilkens 1993) . If a similar scenario is applied to the synthesis and maturation of mucin-type glycoproteins in JHOC-5, the mechanism to be added to the scenario may be how the proportion of Neu5Gc increased in the intracellular free-Sia pool. If the supply of free Sias is mainly dependent on the salvage pathway, the level of free Sias in the pool should be regulated by the activities of sialidases, Sia-specific transporter, Sia-specific N-acetylneuraminate pyruvate lyase. At present, we have little information as to if the activity or efficiency of these enzymes and transporter is equal between Neu5Gc and Neu5Ac. Therefore the initial step of Neu5Gc accumulation remains to be solved. Mucin-type glycoproteins will contribute to the Neu5Gc accumulation in the succeeding steps. We showed that a large portion of intracellular Sias was associated with soluble Neu5Gc-containing glycoproteins, most probably the mucintype glycoproteins that could be either newly synthesized molecules to be excreted or the molecules internalized through the cell membrane. These intracellular mucin-type glycoproteins may be premature molecules on which additional incorporation of Neu5Gc (together with Neu5Ac) occurs. The completely maturated (fully sialylated) molecules, with the highest proportion of Neu5Gc, may stop recycling and anchored on the culture dish with ECM. Thus, the Neu5Gc concentration in the environment of the cell will be kept higher than the medium during cell growth. These Neu5Gc-rich mucin molecules anchored on the dish may have chances to be delivered to the lysosomes, where the joint work of lysosomal sialidase and a Sia-specific transporter (Sialin) contributes to export Neu5Gc-enriched free Sias into the cytoplasm. Further characterization of the soluble Neu5Gc-enriched glycoproteins described in this study is urgent, and our ongoing project.
Apart from the problem of Neu5Gc accumulation in cancer cells, this study showed that in some cell types, the salvage pathway is predominant in supplying free Sias necessary for sialylation of glycoconjugates. It is not concluded, at present stage, if the phenomena observed in the present study are universal features of tumor cells. However, at least it can be said that tumor cells due to the loss of polarization require a large quantity of mucin to cover entire surface of the cell, and thus the supply of free Sias by de novo synthesis will not meet the demand from the vigorous sialylation activity. Loss of topology in cancer cells may also contribute in increasing the cell surface to contact with extracellular Neu5Gc. Results shown in this paper were obtained mainly from the analysis of JHOC-5 cell, since extensive accumulation of Neu5Gc was first recognized in this cell line by unusually high relative proportion of intracellular Neu5Gc. MUC1 expression has been shown not to be specific to epithelial cell, but has been identified in lymphoid cells, B-lymphoblasts, plasma cells, myelomas, selected normal B cells, T and B cell lymphomas, normal proerythrocytes and erythroblasts in bone marrow (cited from Gendler 2001). Thus, the Neu5Gc accumulation in MUC1 (and/or similar cell surface glycoproteins) may also occur in these mucin-producing cells and may possibly contribute to expressing Neu5Gc-antigen on cell surface even when medium concentration of Neu5Gc is extremely low.
Materials and methods
Reagents CMP-Neu5Ac and Neu5Ac used as standards were purchased from Sigma (St. Louis, MO). Authentic samples of Neu5Gc and KDN were isolated from eggs and ovarian fluid of rainbow trout in our past studies (Inoue and Matsumura 1979; Kanamori et al. 1989) . DMB was the product of Dojinbo (Kumamoto, Japan). Diethylaminoethyl (DEAE)-Toyopearl was the product of Tosoh (Tokyo, Japan). Sephadex G-75 and the bicinchoninic acid reagent used for protein assay were products of GE Healthcare (Piscataway, NJ).
Cell lines and culture conditions
Sterile basic culture media in solution were products of Wako (Osaka, Japan) and Sigma and used with the supplement of 10% heat-inactivated FCS (Thermo Trace, Melbourne, Australia) and the addition of penicillin G (100 units/mL) and streptomycin (0.1 mg/mL). All cell lines were purchased from Riken cell bank and cultured in media recommended by the supplier. Cells were inoculated in 90 mm Petri dishes containing 10 mL of the medium and incubated at 37°C in a humidified incubator under 5% CO 2 atmosphere. Cells were harvested at full confluence (usually 4 days after final inoculation). After washing the surface of cells on dishes three times with 5 mL/dish of cold PBS, cells were detached from culture dishes either by brief trypsin treatment (incubation with 1 mL/ dish of 0.05% trypsin and 2 mM ethylenediaminetetraacetic acid (EDTA) in PBS for 3-5 min at room temperature) or by scraping with a plastic cell scraper in PBS containing 2 mM EDTA. Cells were collected by centrifugation for 5 min at 850 g. The supernatant solutions (designated as "trypsin supernatant" or "scraping supernatant") were saved for analyses.
Disruption and fractionation of the cells
Freshly harvested cells were disrupted and fractionated into subcellular compartments by either of the following two methods. Method 1: Disruption and fractionation in a hypotonic medium. Cell pellet obtained from one dish was suspended in 1 mL of 10 mM Tris-HCl (pH 8.0) containing a protease inhibitor cocktail and homogenized by sonication (30 s × 3 times) on ice. The homogenate (a small aliquot was removed for protein assay and Sia analysis) was centrifuged for 15 min at 800 g to remove unbroken cells. The supernatant was centrifuged for 1 h at 100,000 g to separate soluble fraction (S1) and membranous fraction (P1). To S1, 4 volumes of cold ethanol was added, and the mixture was kept at −20°C for overnight and centrifuged for 10 min at 15,000 rpm to separate ES and insoluble ethanol precipitate (EP) fractions. EP was washed with 90% ethanol and suspended in 1 mL of TBS (Tris-buffered saline, pH 8.0) and sonicated. A small portion of the suspension was saved for protein assay and Sia analysis, and the rest was centrifuged to separate clear supernatant (EPS) and insoluble material (EPP), and both fractions were analyzed for Sias. The membrane fraction P1 was washed twice with 1 mL of 10 mM Tris-HCl buffer (pH 8.0) and suspended in a lysis buffer composed of TBS containing 1% Triton, 1 mM EDTA and 0.2% SDS. The suspension was rotated overnight with upside-down movement at 4°. The mixture was then centrifuged for 10 min at 15,000 rpm to separate the supernatant (S2) and the insoluble residue (P2). Method 2: Disruption and fractionation in an isotonic medium. Cell pellet from one culture dish was suspended in 1 mL of 0.25 M sucrose-3 mM Tris-HCl (pH 8.0) and homogenized by hand with a Dounce homogenizer on ice. Disruption of cells was checked by microscopic examination. The homogenate was subjected to differential centrifugation according to the previously described method (Jethmalani et al. 1997) . Briefly, the first pellet P1 (nuclei and unbroken cells) was obtained by centrifugation at 112 g for 10 min, then the nuclear membrane pellet P2 (600 g for 10 min), the mitochondrial pellet P3 (800 g for 10 min), the lysosomal pellet P4 (20,000 g for 10 min), the microsomal pellet P5 (100,000 g for 60 min) and the supernatant S5 (the cytosol) were successively obtained.
Sia analysis
Total Sias were determined in the samples subjected to prehydrolysis in 0.1 M trifluoroacetic acid (TFA) for 80°C, under which conditions maximum liberation of glycan-bound Sias was obtained. After hydrolysis, the sample was vacuum-dried and subjected to derivatization with DMB. DMB-Sias were separated by reverse-phase HPLC on Wakopak Handy-ODS column (250 × 4.6 mm, Wako, Tokyo, Japan), identified and quantified by fluorescence detection (Inoue and Inoue 2003) . For differential analysis of free Sias, CMP-Sias, and glycanbound Sias, a method newly developed by us was used. Briefly, the sample was applied to a 0.5 mL-column of DEAE-Toyopearl 650 M [bicarbonate form]. After washing the column with 2 mL of water, acidic compounds were eluted from the column batchwisely with 1.5 mL each of 20, 40, 100, 200, 500 and 1000 mM ammonium bicarbonate solutions. Authentic free Sias, CMPNeu5Ac and fetuin were eluted with 20, 100 and 500 mM ammonium bicarbonate, respectively, with the yield of 90-100%. When the method was applied to Sia-containing samples from cultured cells, a small proportion of Sias eluted with 20 mM ammonium bicarbonate. Susceptibility to sodium borohydride reduction supported that these Sias might be in free forms. However, a large proportion of Sias that eluted with 100 mM ammonium bicarbonate was relatively stable to acid and most likely glycan bound. To discriminate CMP-Sias and glycanbound Sias, we used the difference in acid stability of Sia linkages between these compounds. We found that incubation of CMP-Neu5Ac in 0.06 M formic acid for 1 h at 55°C cleaved 100% of the β-sialyl linkage in CMP-Neu5Ac, whereas no liberation of Sias occurred from fetuin that contains both α2→3-and α2→6-linked Sia residues. Thus, to estimate the amount of CMP-Sias in this fraction, the DMB reaction was performed without prehydrolysis and using the mild DMB reagent containing 0.06 M formic acid (reaction in our standard DMB reagent containing 0.02 M TFA liberates about 30% of glycan-bound Sias in fetuin). Since only CMP-Sia is β-ketosidic sialyl compound known in mammals, we tentatively consider Sias determined by this method represent CMP-Sias.
Gel filtration chromatography on Sephadex G-75
A column of Sephadex G-75 (fine, 1.0 × 40 cm) was equilibrated and eluted with water. Elution of proteins was followed by the absorbance measurement at 280 nm. In typical experiments, a 20-µL portion from 0.5 mL was withdrawn from every other tube and subjected to Sia analysis by the DMB/HPLC method with prehydrolysis.
Analysis of glycan chains
The high-molecular-weight fraction separated by Sephadex G-75 chromatography of the trypsin supernatant of JHOC cells was freeze-dried and subjected to hydrazinolysis according to the previously described method (Royle et al. 2002) . Glycan chains liberated by hydrazinolysis were then pyridylaminated (Hase 1994) , and the pyridylaminated oligosaccharides were analyzed by reverse-phase HPLC (Iwase et al. 1992 ).
